Daily Health Headlines

Delirium Common in Cancer Patients Seen in ER

👤by Robert Preidt 0 comments 🕔Monday, July 25th, 2016

MONDAY, July 25, 2016 (HealthDay News) -- Delirium is fairly common, yet often missed, in advanced cancer patients who visit emergency departments, a new study says.

Delirium is a serious disturbance in thinking and awareness, according to the U.S. National Cancer Institute.

Researchers looked for delirium in 243 advanced cancer patients seen at an emergency department. The patients were between the ages of 19 and 89. The researchers found that 22 patients -- 9 percent -- had delirium.

Eighteen had mild delirium and four had moderate delirium. Ten percent of the 99 patients older than 65 had delirium, compared with eight percent of the 144 patients younger than 65. This suggests that advanced cancer patients of all ages should be considered at high risk for delirium, the researchers said.

ER doctors failed to diagnose delirium in nine (41 percent) of the patients with delirium, the study said.

The findings were published online July 25 in the journal Cancer.

"We found evidence of delirium in one of every ten patients with advanced cancer who are treated in the emergency department," study leader Dr. Knox Todd, who's with the University of Texas MD Anderson Cancer Center in Houston, said in a journal news release.

"Given that we could only study patients who were able to give consent to enter our study, even 10 percent is likely to be a low estimate," he said.

"We also identified many psychoactive medications that could have contributed to delirium, and sharing this information with treating oncologists may help them avoid such complications in the next patient they treat," Todd added.

The study shows the important role emergency department doctors can play in monitoring the quality of cancer patient care and their potential role in preventing complications of cancer treatment, the researchers said.

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: Cancer, news release, July 25, 2016

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!